Subhanu Saxena
Managing Partner @ New Rhein
Subhanu Saxena is a Series A investor at New Rhein focused on Medical and Manufacturing. Subhanu Saxena is the Global Chief Executive Officer and Managing Director at Cipla Inc. since February 2013. Subhanu was previously Head of Global Product Strategy and Commercialisation at Novartis, where he was also part of the Swiss pharma giant's executive committee. Prior to this most recent position at Novartis, Subhanu was ChiefExecutive Officer and Country President of Novartis UK. Subhanu also has wide non-healthcare experience, working with companies such as Citicorp, the Boston Consulting Group and PepsiCo across markets in Europe, North America, Africa and Asia. Subhanu has a Graduate degree in Engineering from Oxford University and an MBA from INSEAD, France.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Subhanu Saxena invests in
Stages Subhanu Saxena invests in
Countries Subhanu Saxena invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Manufacturing 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| American Injectables is a sterile injectable manufacturer of parenteral drugs with a world-class facility focused on ready-to-use pre-filled syringes and vials. | $10M / Series A / Sep 24, 2020 |
About New Rhein
New Rhein is a venture capital firm focused on healthcare therapeutics and medical devices. Its partners and associates are former industry executives with operational and transactional experience. New Rhein invests in businesses that utilize proven products in new applications (e.g., new indications, new dosage forms, 505(b2)). The company compiles syndicates of operationally focused investors who together bring a wealth of experience and a broad network of relationships to support its portfolio companies in the development, regulatory, reimbursement, marketing, and/or contract manufacturing. New Rhein provides an understanding of what would be attractive to strategic partners and works backward to help its portfolio companies build their value proposition. Prior New Rhein investments have included ophthalmic pharmaceuticals, molecular diagnostics, and respiratory drug/device inhalers.
New Rhein Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ivan Gergel
Managing Partner
|
|||
Paul Navarre
Executive in Residence
|
|||
|
Subhanu Saxena
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Subhanu Saxena invest in?
Subhanu Saxena invests primarily in Medical, Manufacturing and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Subhanu Saxena?
Public channels for Subhanu Saxena include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Subhanu Saxena last invest?
The most recent investment recorded for Subhanu Saxena closed in Sep 2020. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
